News
As the future of rare disease research at Cincinnati Children's is threatened, parents of 13-year-old Charlie Evans plead for ...
The global food allergy market is experiencing remarkable growth, projected to reach a valuation of USD 66.15 Billion by the end of 2033, expanding at a CAGR of 5.2% from its estimated value of USD 39 ...
The US FDA issued a warning on Saturday that some popular allergy medications could cause a rare but severe itching side ...
FDA warns of severe itching risk when stopping long-term use of allergy medications cetirizine and levocetirizine, affecting ...
“She has received quite a bit of antivenom, and the team here has been more than on top of it,” the mother said over the ...
The FDA warns that longtime users of popular allergy medications may experience "severe itching" after stopping use.
Children under a year old should never be given honey. HEPA filters. Studies are mixed about whether air filters help with allergy symptoms. That’s because far more allergens rest on surfaces ...
The combination medicine is used to ease symptoms of common cold and allergies ... when the use of the same drug combination was banned for children below four years. However, the latest action ...
50% of the interactions between children and Ommie were spontaneous. SAN DIEGO — Tests for food and drug allergies can be scary for children. But a robot developed by the Yale University Social ...
according to Drugs.com. And based on early results from this clinical trial, the FDA approved omalizumab as a treatment for food allergies in adults and children as young as 1 year old ...
The U.S. Food and Drug Administration has expanded ... with or without conjunctivitis, to include children ages 5 through 11 years. Odactra is an allergy immunotherapy and is administered ...
according to Drugs.com. And based on early results from this clinical trial, the FDA approved omalizumab as a treatment for food allergies in adults and children as young as 1 year old ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results